Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Active, not recruiting1
Completed1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

active_not_recruiting125%
completed125%
recruiting125%
withdrawn125%

Recent Activity

2 active trials
Showing 4 of 4
completednot_applicable

A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis

NCT04662619
active_not_recruitingnot_applicable

Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity

NCT04769037
recruitingnot_applicable

The BEGIN Study Bifidobacterium Infantis to Newborns: Effects of Modulating the Gut Microbial Composition on Growth, Immune Function and Inflammatory Conditions - a Randomized Placebo-controlled Double-blinded Intervention Trial

NCT06452199
withdrawnphase_1

Probiotic Supplementation in Breastfed Newborn Infants

NCT02286999

Clinical Trials (4)

Showing 4 of 4 trials
NCT04662619Not Applicable

A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis

Completed
NCT04769037Not Applicable

Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity

Active Not Recruiting
NCT06452199Not Applicable

The BEGIN Study Bifidobacterium Infantis to Newborns: Effects of Modulating the Gut Microbial Composition on Growth, Immune Function and Inflammatory Conditions - a Randomized Placebo-controlled Double-blinded Intervention Trial

Recruiting
NCT02286999Phase 1

Probiotic Supplementation in Breastfed Newborn Infants

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4